Engineered vector evades photoreceptor pathology and microglia and CD8

Autophagy in major human diseases

Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium, Molecular Neurodegeneration

Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists

Amyotrophic Lateral Sclerosis: New Insights into Underlying Molecular Mechanisms and Opportunities for Therapeutic Intervention

Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950

CD45 Monoclonal Antibody (30-F11), eFluor™ 450 (48-0451-82)

Gene Therapy for the Nervous System: Challenges and New Strategies

Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950

Caspase 3 Polyclonal Antibody (19677-1-AP)

Tyler KRAUSE, Virology PhD Candidate, Harvard Medical School, MA, HMS, Department of Genetics

Immune responses to retinal gene therapy using adeno-associated viral vectors – Implications for treatment success and safety - ScienceDirect